Singapore-based Raffles Medical Group and Gene Solutions, headquartered in Vietnam, have signed a Memorandum of Understanding (MoU) to streamline patient recruitment for oncology clinical trials, marking a significant milestone in advancing precision medicine in Southeast Asia. Under this partnership, the Raffles Med…
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. and Shanghai ZJ Bio-Tech technology Co., Ltd. jointly announced the official signing of a strategic cooperation agreement on the automated development of innovative biologics. This collaboration aims to jointly tackle drug development bottlenecks by introducing automation…
Novartis announced that it has successfully completed its acquisition of Tourmaline Bio, Inc. With the completion of the acquisition, shares of common stock, par value $0.0001 per share (the “Shares”), of Tourmaline, have ceased trading on the Nasdaq Stock Market LLC and Tourmaline is now an indirect wholly owned subs…
Bristol Myers Squibb and Orbital Therapeutics announced a definitive agreement under which BMS will acquire Orbital, a privately held biotechnology company pioneering a new generation of RNA medicines that reprogram the immune system in vivo, enabling treatments that provide the precision, control, and flexibility nee…
LOTTE BIOLOGICS and SK pharmteco announced that they have signed a Letter of Intent (LOI) for a strategic collaboration to strengthen their competitiveness in the global antibody-drug conjugate (ADC) market. Through this collaboration, the two companies will jointly investigate providing integrated, one-stop CDMO ser…
Chromatin Bioscience is pleased to announce an ongoing research collaboration with Purespring Therapeutics, a precision nephrology company leading the development of targeted, first-in-class genetic therapies to preserve kidney function. The collaboration leverages Chromatin Bio's proprietary synthetic promoter design…
Eli Lilly and Company and Adverum Biotechnologies, Inc., a clinical-stage company pioneering the use of intravitreal gene therapy with the aim of preserving sight for life in highly prevalent ocular diseases, announced a definitive agreement for Lilly to acquire Adverum Biotechnologies, Inc. ("Adverum"), including its…
Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates to profoundly improve people's lives, announced that it has entered into a definitive merger agreement with Novartis AG ("Novartis") which has been unanimously appro…
Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced that it has successfully completed the acquisition of Prothya Biosolutions Belgium BV and its subsidiaries. This strategic move enhances Accord B.V.'s commitment to improving global access to plasma-derived medicines and strengthens its ability to m…
Innovent Biologics announced a strategic global collaboration with Takeda to advance next-generation IO and ADC cancer therapies, with the goal of developing potentially transformative cancer treatments to benefit patients worldwide. This partnership aims to leverage key synergies and accelerate the global developmen…
Page 25 of 37